Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
243 Efficient generation of CD8+ TSCM CD19 chimeric antigen receptor T-cells (CAR-T cells) by treatment with novel cytokine-based scaffolds
Compose a Response to This Article
Other responses
No responses have been published for this article.
